CoChat

Molecular biology of the 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 –isomerase gene family

Simard, Jacques, Ricketts, Marie-Louise, Gingras, Sébastien, Soucy, Penny, Feltus, F. Alex, Melner, Michael H. · 2005 · Endocrine Reviews

The DOI matches its Crossref record; 614 of the 626 references it cites were found in a registry or an index.

Abstract

The 3beta-hydroxysteroid dehydrogenase/Delta(5)-Delta(4) isomerase (3beta-HSD) isoenzymes are responsible for the oxidation and isomerization of Delta(5)-3beta-hydroxysteroid precursors into Delta(4)-ketosteroids, thus catalyzing an essential step in the formation of all classes of active steroid hormones. In humans, expression of the type I isoenzyme accounts for the 3beta-HSD activity found in placenta and peripheral tissues, whereas the type II 3beta-HSD isoenzyme is predominantly expressed in the adrenal gland, ovary, and testis, and its deficiency is responsible for a rare form of congenital adrenal hyperplasia. Phylogeny analyses of the 3beta-HSD gene family strongly suggest that the need for different 3beta-HSD genes occurred very late in mammals, with subsequent evolution in a similar manner in other lineages. Therefore, to a large extent, the 3beta-HSD gene family should have evolved to facilitate differential patterns of tissue- and cell-specific expression and regulation involving multiple signal transduction pathways, which are activated by several growth factors, steroids, and cytokines. Recent studies indicate that HSD3B2 gene regulation involves the orphan nuclear receptors steroidogenic factor-1 and dosage-sensitive sex reversal adrenal hypoplasia congenita critical region on the X chromosome gene 1 (DAX-1). Other findings suggest a potential regulatory role for STAT5 and STAT6 in transcriptional activation of HSD3B2 promoter. It was shown that epidermal growth factor (EGF) requires intact STAT5; on the other hand IL-4 induces HSD3B1 gene expression, along with IL-13, through STAT 6 activation. However, evidence suggests that multiple signal transduction pathways are involved in IL-4 mediated HSD3B1 gene expression. Indeed, a better understanding of the transcriptional factors responsible for the fine control of 3beta-HSD gene expression may provide insight into mechanisms involved in the functional cooperation between STATs and nuclear receptors as well as their potential interaction with other signaling transduction pathways such as GATA proteins. Finally, the elucidation of the molecular basis of 3beta-HSD deficiency has highlighted the fact that mutations in the HSD3B2 gene can result in a wide spectrum of molecular repercussions, which are associated with the different phenotypic manifestations of classical 3beta-HSD deficiency and also provide valuable information concerning the structure-function relationships of the 3beta-HSD superfamily. Furthermore, several recent studies using type I and type II purified enzymes have elegantly further characterized structure-function relationships responsible for kinetic differences and coenzyme specificity.

Overview

Integrity signals

Registry

Crossref · 10.1210/er.2002-0050

Cites

614 of 614 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 614 references

Research works printed but not linked: 22

  1. Labrie, 1996, DHEA and sex steroids: intracrinology in target tissues. J Endocrinol, 150, S1
  2. Labrie, 1999, Role of DHEA transformation into androgens and estrogens in peripheral intracrine tissues., 69
  3. Chieffi, 1965, [Histochemical distribution of 3-β-, 17-α- and 17-β-hydroxysteroid dehydrogenase in the human ovary during the menstrual cycle]., Arch Ostet Ginecol, 70, 492
  4. Tapia Freses, 1965, [Histochemical study of the effect of progesterone on the activity of the enzyme, Δ5, 3β-hydroxysteroid dehydrogenase]., Rev Iber Endocrinol, 12, 393
  5. Luu-The, 1988, Purification and characterization of human placental 3β-hydroxysteroid dehydrogenase/5–4-isomerase, Clin Invest Med, 11, C32
  6. Luu-The, 1992, Human 3β-hydroxysteroid dehydrogenase/Δ5-Δ4-isomerase: characterization of three additional related genes, 426
  7. Turgeon, 1995, Characterization of the unique cofactor specificity of liver-specific rat 3β-hydroxysteroid dehydrogenase by site-directed mutagenesis, 619
  8. Grumbach, 1999, Disorders of sex differentitiation., 1303
  9. Dickson, 1996, Autocrine and paracrine growth factors in the normal and neoplastic breast., 272
  10. Donohoue, 1995, Congenital adrenal hyperplasia., 2929
  11. Simard, 2002, Molecular genetics of 17β-hydroxysteroid dehydrogenase and 5α-reductase deficiencies., 297
  12. de Peretti, 1980, Endocrine studies in two children with male pseudohermaphroditism due to 3β-hydroxysteroid dehydrogenase (3β-HSD) defect., 141
  13. Gendrel, 1979, [Congenital adrenal hyperplasia due to blockade of 3β-hydroxysteroid dehydrogenase]., Arch Fr Pediatr, 36, 647
  14. Forest, 1995, Diagnosis of partial 3β-hydroxysteroid dehydrogenase (3β-HSD) questioned: lessons from long-term study and molecular biology., Horm Res, 44, 55
  15. Simard, 2002, 3β-Hydroxysteroid dehydrogenase/Δ5-Δ4-isomerase deficiency., 209
  16. Chang, 1993, Molecular basis of the type II 3β-hydroxysteroid dehydrogenase (3β-HSD) gene in patients with mild nonclassic (late-onset) 3β-HSD deficiency congenital adrenal hyperplasia (CAH), 396
  17. Swofford, 1990, Phylogeny reconstruction., 411
  18. Yoshimoto, 1988, Case of salt-losing congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency: The first Japanese patient., Acta Paediatr Jpn, 92, 1964
  19. Fisher, 1988, Two brothers with congenital adrenal hyperplasia due to partial 3β-hydroxysteroid dehydrogenase deficiency, Ann Clin Biochem, 25, 133
  20. Lafont, 1984, Le déficit en 3β-ol-déshydrogénase chez l‘enfant
  21. Reiter, 2000, Diagnostic criteria for the diagnosis of 3β-hydroxysteroid dehydrogenase (3β-HSD) deficiency: lessons from hormonal and molecular studies in 2 girls presenting with premature pubarche, Horm Res, 53, 76
  22. Van Seters, 1989, Biochemical concealment of 3βHSD deficiency by long-term steroid substitution, J Steroid Biochem, 36, 174

Cited by

Items 401–500 of 619

Metadata

Authors
Simard, J., Ricketts, M.-L., Gingras, S., Soucy, P., Feltus, F. A., & Melner, M. H.
Affiliations
  • Université Laval (CA)
  • Canada Research Chair in Oncogenetics (J.S., M.-L.R., S.G., P.S.), Oncology and Molecular Endocrinology Research Center, Laval University Medical Center, and Laval University, Quebec, Canada G1V 4G2
  • Vanderbilt University (US)
Venue
Endocrine Reviews
Published
2005-01-04
Volume
26
Issue
4
Pages
525-582
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
OpenAlex
W2107991694
Cited by
620
References
626
Citations by year
2026: 40 · 2025: 32 · 2024: 33 · 2023: 38 · 2022: 32 · 2021: 26 · 2020: 9 · 2019: 31 · 2018: 27 · 2017: 27 · 2016: 27 · 2015: 34 · 2014: 39 · 2013: 30 · 2012: 40
FWCI
2.47
Type
journal article
Language
en
Open access
closed
Locations
  • Endocrine Reviews (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Keywords
3β-hydroxysteroid dehydrogenase, HSD3B1, HSD3B2, gene family evolution, congenital adrenal hyperplasia, steroidogenic factor 1, DAX-1, STAT5, STAT6, epidermal growth factor, IL-4, IL-13, transcriptional regulation
MeSH terms
Adrenal Glands, Amino Acid Sequence, Animals, Base Sequence, Female, Gonads, Humans, Isoenzymes, Male, Molecular Sequence Data, Multienzyme Complexes, Organ Specificity, Phylogeny, Placenta, Pregnancy, Progesterone Reductase, Promoter Regions, Genetic, Species Specificity, Steroid Isomerases, Structure-Activity Relationship, Gene Expression Regulation, Enzymologic, Evolution, Molecular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.